It has been reported that IGFBP3 is a marker of culture‐induced HSC activation,25 and could be used as a diagnostic and therapeutic target for alcoholic fatty liver and liver fibrosis.26 This evidence concerns the gene IGFBP3 and Hepatic steatosis.